Global Health Limited · ASX:GLH

Global Health — H1 FY2022 Earnings Presentation

19 slides from Global Health's earnings presentation, Feb 16, 2022

  1. Slide 1: FY22 Half Year Presentation

    FY22 Half Year Presentation Results and Business Update 16 February 2022 Global Health Limited (ASX:GLH)

  2. Slide 2: Disclaimer

    Disclaimer This Presentation contains summary information about Global Health Limited ACN 091 377 892 (Global Health or the Company) and its activities as at 31 December 2021. The information in this Presentation is of a general nature and does not purport to be complete or comprise all information

  3. Slide 3: Our Performance

    Our Performance >

  4. Slide 4: At a Glance

    At a Glance Available Cash Total Revenue & Income Total cash and Total customer cash equivalents revenue $2,930,865 of $7,041,454 FY20 H1 FY21 H1 FY22 H1 down 6.32% PCP FY20 H1 FY21 H1 FY22 H1 Total Expenses Operating Cashflow Total expenses for Total operating the half increased cashflow for the ha

  5. Slide 5: Recurring Revenue and Other Customer Revenue

    FY19 H1 FY20 H1 FY21 H1 FY19 H1 FY20 H1 FY21 H1 Recurring Revenue Other Customer Revenue Recurring revenue base of the Professional services were business increased 9.25% from PCP materially down 49% PCP up $212k $(410)k

  6. Slide 6: Revenue Detail

    Revenue Detail ✓ Subscription revenue continues to grow half on half, with the Dec-19 HY Dec-20 HY Dec-21 HY FY22 recurring group revenue Subscription Revenue $1,699,313 $1,950,150 $2,119,926 growing by an additional 9.25%/$212K. The Company’s Expansion Revenue $ 259,553 $ 346,576 $ 389,141 MasterCa

  7. Slide 7: Key Updates

    Key Updates >

  8. Slide 8: Sales Focus

    Sales Focus Establishing New Sales New Contract Wins • Sales activity has lifted materially Mental Health Solutions • Account Management discipline • Waratah Intervention Services and engagement in full swing. • NSW Rural Fire Services • Echuca Headspace Successful Implementations Medical Discharge

  9. Slide 9: Marketing Focus

    Marketing Focus Increased Campaign Activity MasterCare Strategy • Successful EMR content • EMR and PAS strategy syndication resulting in strong lead generation. • Deeper understanding of digital pathways to market. Half Two Campaigns Brand Simplification • New EMR content campaigns • Solution focus

  10. Slide 10: Public Relations, Investor Relations & Events

    Public Relations, Investor Relations & Events Public Relations Investor Relations • Confirmation of client wins • GLH Investor deck Feb (ongoing) • Reach Investor Feb • Launch of Mconnect • Baker Young Roadshow Feb • Launch of EMR in-patient • Talking Health Tech podcast • Launch of HH integration M

  11. Slide 11: Product Focus

    Product Focus Enhanced Capability • Delivered PRODA upgrades to our full product suite in line with the mandatory Medicare changes due in March. • Delivered ePrescribing enhancements to our PrimaryClinic solution. • Achieved ISO27001 certification – establishing significant credibility for the pursu

  12. Slide 12: Opportunities

    Opportunities In-Organic Opportunities Multiple indirect sales channel discussions in progress, initially targeting the underserviced and larger ASEAN consumer markets of Malaysia, Indonesia, Vietnam and Philippines. Reseller engagements are focussed on the Company's MasterCare+ Provider platform, H

  13. Slide 13: Moving Forward

    Moving Forward >

  14. Slide 14: Sector Trends

    Patient Management • Better At Home Government initiative that aligns well with our capability • Royal Commission recommendations are now impacting on the workflow and direction of health organisations throughout the health sector. • Outcome based charging is emerging • A shift from PAS to EMR adopt

  15. Slide 15: Our Growth

    Our Growth ✓ Global Health enters the 2nd half of the year with a strong balance sheet and a positive pipeline of opportunity. ✓ Many of the resources hired in half one are now settled into their roles and are becoming significantly more productive. ✓ Global Health’s current and in train capabilitie

  16. Slide 16: Our Growth

    Our Growth Global Health will continue to execute on our strategy to accelerate growth, focused on increasing share in our three core markets - Community Health Services, Hospitals and Mental Health. A focus on product expansion within existing customers and the acquisition of new customers, in comb

  17. Slide 17: Forward Outlook

    Forward Outlook > Half One > Half Two 1. Sales and Marketing drive to lift opportunity 1. SaaS upgrade strategy and review development a) Develop scoping and costing a) Establish core sales functions b) Map milestone deliverables for new market b) Commence campaigns for EMR, PAS, Hot expansion. Heal

  18. Slide 18: Our Board of Directors

    ROBERT KNOWLES AO Independent Non-Executive Director Our Board of Directors A former Victorian Minister of Health, Housing and Aged Care, and a former Commissioner with the National Mental Health Commission and National Health and Hospital Reform Commission, Robert’s leadership roles include Chair o

  19. Slide 19: For Further Information

    Michael Davies Chief Executive Officer, Global Health Limited T: (03) 9675 0614, M: 0429 306 650 E: michael.davies@global-health.com For Further Information Rod North (Investor Relations, Media & PR) Managing Director, Bourse Communications T: (03) 9510 8309, M: 0408 670 706 E: rod@boursecommunicati

Global Health — H1 FY2022 Earnings Presentation on 6ix